A detailed history of Dlk Investment Management, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Dlk Investment Management, LLC holds 7,600 shares of RNA stock, worth $331,740. This represents 0.13% of its overall portfolio holdings.

Number of Shares
7,600
Previous 7,600 -0.0%
Holding current value
$331,740
Previous $310 Million 12.44%
% of portfolio
0.13%
Previous 0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$22.73 - $40.85 $79,555 - $142,975
-3,500 Reduced 31.53%
7,600 $310 Million
Q4 2023

Apr 09, 2024

BUY
$4.87 - $9.37 $54,057 - $104,006
11,100 New
11,100 $100 Million

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $2.28B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Dlk Investment Management, LLC Portfolio

Follow Dlk Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dlk Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dlk Investment Management, LLC with notifications on news.